Show simple item record

dc.contributor.authorLeung, Keith Sai Kit
dc.contributor.authorRadford, Danny
dc.contributor.authorHuang, Helen
dc.contributor.authorLakhani, Ishan
dc.contributor.authorLi, Christien Ka Hou
dc.contributor.authorHothi, Sandeep Singh
dc.contributor.authorWai, Abraham Ka Chung
dc.contributor.authorLiu, Tong
dc.contributor.authorTse, Gary
dc.contributor.authorLee, Sharen
dc.date.accessioned2024-06-27T09:23:37Z
dc.date.available2024-06-27T09:23:37Z
dc.date.issued2023-01-11
dc.identifier.pmid36628595
dc.identifier.doi10.1111/anec.13030
dc.identifier.urihttp://hdl.handle.net/10147/641794
dc.descriptionBackground and Objectives Risk stratification in Brugada syndrome remains a difficult problem. Given the male predominance of this disease and their elevated risks of arrhythmic events, affected females have received less attention. It is widely known that symptomatic patients are at increased risk of sudden cardiac death (SCD) than asymptomatic patients, while this might be true in the male population; recent studies have shown that this association might not be significant in females. Over the past few decades, numerous markers involving clinical symptoms, electrocardiographic (ECG) indices, and genetic tests have been explored, with several risk‐scoring models developed so far. The objective of this study is to review the current evidence of clinical and ECG markers as well as risk scores on asymptomatic females with Brugada syndrome. Findings Gender differences in ECG markers, the yield of genetic findings, and the applicability of risk scores are highlighted. Conclusions Various clinical, electrocardiographic, and genetic risk factors are available for assessing SCD risk amongst asymptomatic female BrS patients. However, due to the significant gender discrepancy in BrS, the SCD risk amongst females is often underestimated, and there is a lack of research on female‐specific risk factors and multiparametric risk scores. Therefore, multinational studies pooling female BrS patients are needed for the development of a gender‐specific risk stratification approach amongst asymptomatic BrS patients.en_US
dc.language.isoenen_US
dc.rights© 2023 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectbrugada syndromeen_US
dc.subjectgender differenceen_US
dc.subjectrisk stratificationen_US
dc.subjectsudden cardiac deathen_US
dc.titleRisk stratification of sudden cardiac death in asymptomatic female Brugada syndrome patients: A literature review.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.identifier.eissn1542-474X
dc.identifier.journalAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Incen_US
dc.source.journaltitleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
dc.source.volume28
dc.source.issue2
dc.source.beginpagee13030
dc.source.endpage
refterms.dateFOA2024-06-27T09:23:40Z
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
ANEC-28-e13030.pdf
Size:
304.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Except where otherwise noted, this item's license is described as © 2023 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.